Panoramic view of common fusion genes in a large cohort of Chinese de novo acute myeloid leukemia patients

Leuk Lymphoma. 2019 Apr;60(4):1071-1078. doi: 10.1080/10428194.2018.1516876. Epub 2018 Oct 2.

Abstract

Fusion genes are major molecular biological abnormalities in hematological malignancies. This study aimed to depict the common recurrent gene-fusion landscape in acute myeloid leukemia (AML). 3135 de novo AML cases were enrolled and 36 recurrent fusion genes were assessed using multiplex-nested RT-PCR. Twenty-three distinct fusion genes were detected in 1292 (41.21%) cases. The incidence of fusion genes was higher in pediatric AML than in adult cases. The pediatric patients had higher incidences of RUNX1-RUNX1T1, KMT2A-MLLT3, KMT2A-MLLT10, KMT2A-MLLT11, KMT2A-MLLT6, and FUS-ERG, whereas KMT2A-PTD was more common in adult patients. The occurrence of molecular abnormalities involving the KMT2A gene and CBFB-MYH11 was lower in Chinese pediatric AML compared to Western reports. The incidence of RUNX1-RUNX1T1 was higher in both pediatric and adult patients in our study than in Western countries. This study provides a genetic landscape of common fusion genes in Chinese AML and confirms different incidences between age groups and races.

Keywords: Acute myeloid leukemia; adult; fusion genes; pediatric.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Asian People / genetics
  • Biomarkers, Tumor
  • Child
  • Child, Preschool
  • China
  • Female
  • Gene Expression Profiling* / methods
  • Humans
  • Infant
  • Leukemia, Myeloid, Acute / diagnosis
  • Leukemia, Myeloid, Acute / genetics*
  • Male
  • Middle Aged
  • Multiplex Polymerase Chain Reaction
  • Oncogene Proteins, Fusion / genetics*
  • Young Adult

Substances

  • Biomarkers, Tumor
  • Oncogene Proteins, Fusion